Oral immune regulation using colitis extracted proteins for treatment of Crohn&rsquo;s disease: Results of a phase I clinical trial

doi:10.3748/wjg.v11.i20.3105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2720)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

279

HTML

2256

Figures (1-9)

185

Sum=2720

May 28, 2005 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. May 28, 2005; 11(20): 3105-3111
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3105

Full Size Figure Download Figure

Figure 9 Effect of the study drug on serum IL-10 levels in 8/10 patients in whom a significant increase was observed during treatment. Baseline ratio (open bars) as compared to level of maximal increase (black bars).

Citation: Israeli E, Goldin E, Shibolet O, Klein A, Hemed N, Engelhardt D, Rabbani E, Ilan Y. Oral immune regulation using colitis extracted proteins for treatment of Crohn’s disease: Results of a phase I clinical trial. World J Gastroenterol 2005; 11(20): 3105-3111
URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3105.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i20.3105